Bottom line
RSPH vs IYH: the short answer
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.
IYH is cheaper at 0.37% vs 0.4% — a difference of $3.00 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +4.7% for RSPH.
Updated Nov 19, 2026
RSPH vs IYH side by side
| RSPH | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.4% | 0.37% |
| Annual cost per $10k | $40 | $37 |
| 10-yr cost on $10k (prospectus) | $505 | $468 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +9.3% | +13.1% |
| 5-yr return (annualized) | +4.7% | +7.0% |
| 10-yr return (annualized) | +8.2% | +9.4% |
| Best quarter | +17.5% | +15.3% |
| Worst quarter | −14.3% | −12.7% |
| Net assets (fund) | $766.9M | $3.6B |
| Number of holdings | 63 | 103 |
| Portfolio turnover | 24% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RSPH | IYH | Difference |
|---|---|---|---|
| 2025 | +9.3% | +13.1% | −3.8% |
| 2024 | −0.8% | +3.1% | −3.9% |
| 2023 | +3.9% | +2.1% | +1.9% |
| 2022 | −9.2% | −4.4% | −4.9% |
| 2021 | +23.0% | +23.4% | −0.4% |
| 2020 | +18.9% | +15.5% | +3.4% |
| 2019 | +25.3% | +20.8% | +4.5% |
| 2018 | −0.3% | +5.9% | −6.2% |
| 2017 | +23.4% | +22.3% | +1.1% |
| 2016 | −4.5% | −2.8% | −1.7% |
Source: Fund prospectus bar charts
Holdings overlap
7 of RSPH's top 25 holdings also appear in IYH's top 25.
| Holding | RSPH | IYH |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1.96% | 1.27% |
| Thermo Fisher Scientific Inc. | 1.84% | 3.52% |
| Abbott Laboratories | 1.83% | 3.02% |
| Bristol-Myers Squibb Co. | 1.82% | 2.20% |
| Amgen Inc. | 1.77% | 3.42% |
| Becton, Dickinson and Co. | 1.73% | 0.78% |
| AbbVie Inc. | 1.73% | 7.32% |
Source: SEC Form N-PORT
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between RSPH and IYH?
Which is cheaper, RSPH or IYH?
Should I own both RSPH and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.